Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Eric I-Fu Tsao
Introduction
Eric I-Fu Tsao is a notable inventor based in Potomac, MD (US). He has made significant contributions to the field of immunogenic viral compositions. His work focuses on developing methods that enhance the viability of viruses for mass vaccinations.
Latest Patents
Eric I-Fu Tsao holds a patent for "Stable, spray dried, immunogenic, viral compositions." This patent involves genetically engineered, replication-deficient viruses such as adenoviruses, poxviruses, MVA viruses, and baculoviruses. These viruses encode one or more antigens of interest, including those for tuberculosis, malaria, and HIV. The innovative aspect of his patent is the use of a mannitol-cyclodextrin-trehalose-dextran (MCTD) formulation to create a powder that maintains the viability of the viruses during storage, even in humid conditions. He has 1 patent to his name.
Career Highlights
Eric I-Fu Tsao is currently associated with the Aeras Global TB Vaccine Foundation. His work at Aeras focuses on advancing vaccine technologies to combat infectious diseases. His research has the potential to significantly impact public health by improving vaccination strategies.
Collaborations
Eric collaborates with various professionals in the field, including his coworker Tom Han Jin. Their combined expertise contributes to the innovative projects at Aeras.
Conclusion
Eric I-Fu Tsao's contributions to the field of immunogenic viral compositions highlight his role as an influential inventor. His work not only advances scientific knowledge but also has the potential to improve global health outcomes through effective vaccination strategies.